Maintaining remission in a patient with vasculitis

Nature Clinical Practice Rheumatology

Volumn 4, Issue 9, 2008, Pages 499-504

  Flossmann, Oliver ^a   Jayne, David R W ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXYSPERGUALIN; AZATHIOPRINE; C REACTIVE PROTEIN; CEFOTAXIME; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; MYELOBLASTIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; RITUXIMAB;

ADULT; ARTHRALGIA; ARTICLE; BRONCHUS DISEASE; CASE REPORT; CLINICAL FEATURE; CONJUNCTIVITIS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; HEADACHE; HEARING IMPAIRMENT; HEMATURIA; HEMOPTYSIS; HUMAN; HUMAN TISSUE; LOW DRUG DOSE; LUNG HEMORRHAGE; LUNG INFECTION; MALE; MULTIPLE CYCLE TREATMENT; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEINURIA; RELAPSE; REMISSION; SKIN BIOPSY; WEGENER GRANULOMATOSIS;

ADULT; ANTIBODIES, MONOCLONAL; AZATHIOPRINE; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; GUANIDINES; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; MALE; MYCOPHENOLIC ACID; PLASMA EXCHANGE; PREDNISOLONE; RECURRENCE; REMISSION INDUCTION; WEGENER GRANULOMATOSIS;

EID: 51149121174     PISSN: 17458382     EISSN: 17458390     Source Type: Journal    
DOI: 10.1038/ncprheum0863     Document Type: Article

References (20)

1. Jennette JC et al. (1994) Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 37: 187-192
2. Jayne D et al. (2003) A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349: 36-44
3. Jayne DR et al. (2007) Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 18: 2180-2188
4. Luqmani RA et al. (11994) Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 87: 671-678
5. Cordier JF et al. (1990) Pulmonary Wegener's granulomatosis: A clinical and imaging study of 77 cases. Chest 97: 906-912
6. Hellmich B et al. (2007) EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: Focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 66: 605-617
7. Reinhold-Keller E et al. (2000) An interdisciplinary approach to the care of patients with Wegener's granulomatosis: Long-term outcome in 155 patients. Arthritis Rheum 43: 1021-1032
8. Stegeman CA et al. (1994) Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 120: 12-17
9. Lapraik C et al. (2007) BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology (Oxford) 46: 1615-1616
10. Hoffman GS et al. (1992) Wegener granulomatosis: An analysis of 158 patients. Ann Intern Med 116: 488-498
11. de Groot K et al. (2001) The value of pulse cyclophosphamide in ANCA-associated vasculitis: Meta-analysis and critical review. Nephrol Dial Transplant 16: 2018-2027
12. de Groot K et al. (2005) Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 52: 2461-2469
13. Koukoulaki M and Jayne DR (2006) Mycophenolate mofetil in anti-neutrophil cytoplasm antibodies-associated systemic vasculitis. Nephron Clin Pract 102: C100-c107
14. Birck R et al. (2003) 15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: A six-month open-label trial to evaluate safety and efficacy. J Am Soc Nephrol 14: 440-447
15. Schmitt WH et al. (2005) Prolonged treatment of refractory Wegener's granulomatosis with 15-deoxyspergualin: An open study in seven patients. Nephrol Dial Transplant 20: 1083-1092
16. Smith KG et al. (2006) Long-term companson of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment. Arthritis Rheum 54: 2970-2982
17. Keogh KA et al. (2006) Rituximab for refractory Wegener's granulomatosis: Report of a prospective, open-label pilot trial. Am J Respir Crit Care Med 173: 180-187
18. Stasi R et al. (2006) Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab. Rheumatology (Oxford) 45: 1432-1436
19. Metzler C et al. (2007) Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis. Rheumatology (Oxford) 46: 1087-1091
20. Stegeman CA et al. for the Dutch Co-Trimoxazole Wegener Study Group (1996) Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulornatosis. N Engl J Med 335: 16-20